{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:4369359",
      "entity_text" : "sitagliptin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "It was confirmed that sitagliptin decreased that HbA1c level irrespective of the concomitant medications used, being effective for HbA1c, fasting plasma glucose, and postprandial glucose until 24 weeks of treatment.",
  "reading_complete" : "2020-08-02T16:13:26Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T16:12:32Z",
  "trigger" : "decreased",
  "evidence" : [ "sitagliptin decreased that HbA1c level irrespective of the concomitant medications used, being effective for HbA1c, fasting plasma glucose, and postprandial glucose" ],
  "pmc_id" : "3651072",
  "score" : 0
}